Vancouver goes orange for World Preeclampsia Day

News

Posted on

Tonight, iconic buildings around Vancouver will light up in orange for World Preeclampsia Day. BC Place, Vancouver City Hall, North Vancouver City Hall, Vancouver Convention Centre and Science World will all have orange lights to raise awareness for preeclampsia, a dangerous pregnancy complication that can lead to serious health problems or death for both mother and baby.

PRE-EMPT, a multi-national global health project coordinated out of the University of British Columbia, BC Children’s Hospital, and the Centre for International Child Health, is one of the co-sponsors of World Preeclampsia Day. PRE-EMPT is dedicated to reducing the devastating impact of preeclampsia and related disorders worldwide.

“Preeclampsia is relatively common and has a huge impact on families and communities across the world,” says Dr. Peter von Dadelszen. “At PRE-EMPT, we’re very pleased to join health organizations worldwide in promoting awareness of this devastating condition as part of World Preeclampsia Day.”

Dr. von Dadelszen is the Principal Investigator of PRE-EMPT, Affiliate Investigator at BC Children’s Hospital, Honorary Professor of Obstetrics and Gynecology at UBC, and Professor of Women’s Health at King’s College London.

Preeclampsia usually occurs during the second half of pregnancy and is characterized by the sudden onset of high blood pressure with signs of damage to another organ system, most commonly the liver and kidneys. Women with preeclampsia need to be monitored closely by health care professionals and may need to have their babies delivered early. If not properly managed, preeclampsia can result in seizures and organ damage that threaten the life of both mother and baby.

Preeclampsia affects eight to 10 per cent of pregnancies and is a leading cause of death for moms and babies. Worldwide, 76,000 women and 500,000 infants die as a result of preeclampsia every year.

Since 2010, PRE-EMPT has been tackling preeclampsia across the world by developing, testing and introducing new ways to monitor, prevent and treat the condition. PRE-EMPT research projects include studies on whether increased calcium intake prior to pregnancy can prevent preeclampsia and evaluation of the Preeclampsia Integrated Estimate of RiSk (PIERS) model for predicting which women will develop dangerous complications from preeclampsia.

PRE-EMPT is supported by the University of British Columbia, King’s College London, the Bill & Melinda Gates Foundation, Canadian Institutes of Health Research, the Michael Smith Foundation for Health Research, the World Health Organization and BC Children’s Hospital Foundation.

BCCHR Communications
More by this Author

Research News

Every day, BCCHR researchers work towards breakthroughs to transform the lives of kids in BC and around the world. Learn about our latest innovations and advancements in child health.

  • News

    Genetic tools aren’t just for future patients, but cold cases too

    The world of genomic sequencing has changed dramatically in the last few decades. When the world attempted to sequence the very first human genome in the 1990s, the project took years and billions of dollars. Today, with the emergence of next-generation sequencing, a complete human genome can now be sequenced within a few days for…

    Read more
  • Dads with kid in the pool
    News

    Research supports BC families in building healthy habits to prevent childhood obesity

    Unhealthy eating patterns, low physical activity, and a lot of sedentary or screen-related habits are linked to childhood obesity risk, which can lead to elevated blood pressure, sleep problems, orthopedic issues, and mental health challenges. Obesity-prevention resources that only focus on providing information often fall short because many families already know the basics. The biggest…

    Read more
  • News

    First-in-world BC patient successfully treated for rare immune disease

    A new paper published in New England Journal of Medicine details how an 18-year-old patient being treated at BC Children’s Hospital (BCCH) for a rare disease called chronic granulomatous disease (CGD) became the first person ever to receive and be cured by a gene modification treatment known as “Prime Editing.”

    Read more

Donate to Research

With your support, we believe there’s nothing we can’t do. Funding helps bring hope out of the laboratory and into the clinic — to save and improve children’s lives.

donate now